Shanghai, China · Founded 2018 · In IPO Registration
Operator of a biopharmaceutical company focusing on novel therapies discovery and development primarily for kidney diseases and their complications, as well as other chronic conditions. Alebund Pharmaceuticals is based in Shanghai, China and was founded in 2018. Its last reported valuation was $530 million in Oct 2025. It has raised $270 million.
Last reported valuation
$530.5M
Oct 2026
Priced at
—
Total raised
$269.8M
Last round
—
Team — not yet on record
No current team members for Alebund Pharmaceuticals are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Alebund Pharmaceuticals with a free account
·The complete investor list: 25 names
·Watch Alebund Pharmaceuticals: the Monday email on marks, rounds and moves
